The use of radionuclides for tumor therapy

Beierwaltes, 1982, J. Nucl. Med., 23, 561 Ingold, 1965, J. Roentgenol., 93, 200 Pizzarello, 1982, 134 Kraut, 1972, Hepatic Effects of Irradiation, 182 Koral, 1982, Med. Phys., 9, 497, 10.1118/1.595096 Shapiro, 1984, Clin. Endocr., 20, 189, 10.1111/j.1365-2265.1984.tb00074.x Sisson, 1985, J. Nucl. Med., 25, 197 Rosen, 1983, Ann. Clin. Lab. Sci., 13, 173 Miller, 1983, Blood, 62, 988, 10.1182/blood.V62.5.988.988 Epenetos, 1982, Lancet, ii, 1000 Stern, 1982, 245 Yeh, 1979, J. Radiopharm. Chem., 53, 327, 10.1007/BF02517931 Fawwaz R. A., Srivastava S. C., Ferrone S. et al. Unpublished results (1985). Casarett, 1968, 220 Fawwaz, 1984, J. Nucl. Med., 25, 796 Ferrone, 1983, Imaging with 1–131, 1–123, or Tc-99m labeled anti-HMW-MAA MoAb and their Fab2 fragments in patients with melanoma Doherty, 1984, J. Nucl. Med., 25, 112 Fawwaz, 1985, J. Nucl. Med., 26, 488 Larson, 1983, J. Clin. Invest., 72, 2101, 10.1172/JCI111175 Wang, 1984, J. Nucl. Med., 25, 56 Wang, 1985, J. Nucl. Med., 26, 46 Piver, 1972, Obstet. Gynecol., 40, 10.1097/00006250-197207000-00009 Epenetos, 1984, Lancet, i, 1441